Vascular endothelial growth factor is increased in patients with preeclampsia

American Journal of Reproductive Immunology

Volumn 38, Issue 4, 1997, Pages 302-306

  Kupferminc, Michael J ^a   Daniel, Yair ^b   Englender, Talma ^b   Baram, Amiram ^b   Many, Ariel ^b   Jaffa, Ariel J ^b   Gull, Ilax ^b   Lessing, Joseph B ^b  

^a Serlin Maternity Hospital   (Israel)

^b NONE

Author keywords

Preeclampsia; Pregnancy; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; LABOR; MATERNAL PLASMA; PARITY; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0030823899     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00519.x     Document Type: Article

References (36)

1. Roberts JM, Martin EE, Golden A, Taylor RM: Sera from preeclamptie women specifically activate human umbilical endothelial cells in vitro: Morphological and biochemical evidence. Am J Reprod Immunol 1992; 27:101-108.
2. Roberts JM, Taylor RN, Musici TJ, Rogers GM, Hubel CA, McLaughlin MK: Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
3. Rodgers GM, Taylor RN, Roberts JM: Preeclampsia is associated with a serum factor that is cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159:908-914.
4. Ferrara N, Houck KA, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
5. Leung D, Cachianes G, Kuang W-J, Goddel D, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-1309.
6. Brogi E, Schattteman G, Wu T, Kim EA, Vatticovski L, Keyt B, Isner JM: Hypoxia induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996; 97:469-476.
7. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995; 36:127-137.
8. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845.
9. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD, Smith SK: Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993; 99:609-615.
10. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 2:1535-1545.
11. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-985.
12. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascylar hyperpermeability, and angiogensis. Am J Pathol 1995; 146:1029-1039.
13. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 271:603-606.
14. Mustonen T, Alitalo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995; 129:895-898.
15. Carmiliet PV, Ferrara G, Breier S, Pollefeyt S, Kiechens L, Gertsenstein M, Fahrig M, Vandenhoec A, Harpal K, Eberhardt C: Abnormal blood vessel development and lethality in embryos lacking a VEGF allele. Nature 1996; 380:435-439.
16. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O' Shea KS, Powell-Braxton L, Hillan KJ Moore MW: Heterozygous embryonic lethality Induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-442.
17. Baker PN, Krasnow J, Roberts JM, Yeo KT: Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86:815-821.
18. th Annual Meeting of the Society for Gynecologic Investigation, 1997, San Diego, California, Abstract 458.
19. Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K: Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996; 17:111-121.
20. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, Inser JM: Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995; 279:31189-31195.
21. Cao Y, Linden P, Shima D, Browne F, Folkman J: In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest 1996; 98:2507-2511.
22. Park JE, Chen HH, Winer J, Houch KA, Ferrera N: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not Flk-1/KDR. J Biol Chem 1994; 269:25646-25654.
23. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991; 138:213-221.
24. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yen TK, Berse B, Jaackman RW, Dvorak KM, Dvorak HF: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993; 12:303-324.
25. th Annual Meeting of the Society for Gynecologic Investigation, 1997, San Diego. California. Abstract 663.
26. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK: VEGF mRNA levels in placentae from pregnancies complicated by precclampsia. Br J Obstet Gynecol 1996; 103:1191-1196.
27. Many A, Hubel CA, Roberts JM: Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996; 174:288-291.
28. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996; 98:1667-1675.
29. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML: Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-1759.
30. Kupferminc MJ, Peaceman AM, Adeka D, Wallach D, Socol ML: Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88:420-427.
31. Ryuto M, Ono M, Izumo H, Yoshida S, Weich HA, Kohno K, Kuwano M: Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. J Biol Chem 1996; 271:28220-28228.
32. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271:736-741.
33. Jackson MR, Carney EW, Lye SJ, Ritchie JW: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 1994; 15:341-353.
34. Houck KA, Ferrera N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5:1806-1814.
35. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Falangan JG, Tsang MLS: Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996; 271:3154-3162.
36. Kendall RL, Thomas KA: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90:10705-19709.